Invitae’s study, in collaboration with The Outer Banks Hospital, found universal hereditary cancer genetic testing for all breast cancer patients aligns with the American Society of Breast Surgeons’ guidelines. It showed that 91.4% of patients took up the testing, which improved patient outcomes, optimized resources and informed treatment plans. The study also supports the idea that genetic testing should be adopted as a standard in breast cancer care.
Deploying AI-powered solutions can save lives through enriching disease screenings
Artificial intelligence (AI) could improve care quality and patient identification, reducing the cost of chronic disease management, which accounts for 90% of America’s $4.1tn yearly
